Give a gift to Leukaemia Care and help us support leukaemia patients
We use cookies to provide a better service. Keep browsing if you're happy with this, or read our cookie policy.
Menu
08088 010 444
Take a moment to catch up with our latest news, current campaigns and appeals.
2nd January 2018
In August 2017, NICE rejected the use of inotuzumab ozogamicin for the treatment of relapsed, or refractory, b-cell acute lymphoblastic leukaemia (ALL).
5th October 2017
NICE use the Cancer Drugs Fund to grant access to venetoclax for treating chronic lymphocytic leukaemia patients.
4th October 2017
Brentuximab vedotin is indicated for the treatment of adults with relapsed or refractory ALCL and has been available for use through the Cancer Drugs Fund since 2013.
2nd October 2017
We want to say thank you to everyone who went spotty, shared their stories and spread the word about #SpotLeukaemia this Blood Cancer Awareness Month.
22nd September 2017
September 22nd marks World CML Day and this year the motto has seen an important addition, from “today, together we are treated” to “Today, together we are treated, tomorrow we need a cure”.
11th September 2017
In June, at the European Haematology Association conference, members from acute leukaemia patient advocate groups across the globe joined together to discuss the creation of an Acute Leukemia Advocates Network (ALAN).
5th September 2017
Leukaemia Care is now the charity of the year for the Sainsbury’s Blackpole store in Worcester. Find out what we have planned for our partnership in our latest update.
1st September 2017
Our latest report, Living with Leukaemia looks has uncovered a worrying lack of awareness among the public and GPs. Read on to find out more.
Find a Support Group
Meet with others who have been or are going through a similar journey to you
Help & Resources
Downloadable information for patients, friends or family members at the click of a button
Newsletter Signup.
Keep in touch with Leukaemia Care
chat